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Abstract
Adolescence is characterized behaviorally by increased impulsivity and risk-taking that declines in
parallel with maturation of the prefrontal cortex and executive function. In the brain, the receptor
for advanced glycation end products (RAGE) is critically involved in neurodevelopment and
neuropathology. In humans, the risk of alcoholism is greatly increased in those who begin
drinking between 13 and 15 years of age, and adolescents binge drink more than any other age
group. We have previously found that alcoholism is associated with increased expression of
neuroimmune genes. This manuscript tested the hypothesis that adolescent binge drinking
upregulates RAGE and Toll-like receptor (TLR) 4 as well as their endogenous agonist, high-
mobility group box 1 (HMGB1). Immunohistochemistry, Western blot, and mRNA analyses
found that RAGE expression was increased in the human post-mortem alcoholic orbitofrontal
cortex (OFC). Further, an earlier age of drinking onset correlated with increased expression of
RAGE, TLR4, and HMGB1. To determine if alcohol contributed to these changes, we used an
adolescent binge ethanol model in rats (5.0 g/kg, i.g., 2-day on/2-day off from postnatal day [P] 25
to P55) and assessed neuroimmune gene expression. We found an age-associated decline of
RAGE expression from late adolescence (P56) to young adulthood (P80). Adolescent intermittent
ethanol exposure did not alter RAGE expression at P56, but increased RAGE in the young adult
PFC (P80). Adolescent intermittent ethanol exposure also increased TLR4 and HMGB1
expression at P56 that persisted into young adulthood (P80). Assessment of young adult frontal
cortex mRNA (RT-PCR) found increased expression of proinflammatory cytokines, oxidases, and
neuroimmune agonists at P80, 25 days after ethanol treatment. Together, these human and animal
data support the hypothesis that an early age of drinking onset upregulates RAGE/TLR4-HMGB1
and other neuroimmune genes that persist into young adulthood and could contribute to risk of
alcoholism or other brain diseases associated with neuroinflammation.
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The innate immune system has increasingly been implicated in neurodevelopment and
neurodegeneration. Both the receptor for advanced glycation end products (RAGE) and
Toll-like receptors (TLRs) are involved in neurogenesis and neurite outgrowth (Chou et al.
2004; Okun et al. 2011), partly through interactions with amphoterin (i.e., high-mobility
group box 1 [HMGB1]; Chou et al. 2004; Merenmies et al. 1991). Indeed, blockade of
RAGE in P19 embryonic stem cells prevents neuronal differentiation and inhibits neurite
outgrowth, which appear to be mediated through downstream Rac1/Cdc42 pathways (Wang
et al. 2008). In a similar fashion, TLRs exert a neuromodulatory role in neural development
as knockout of TLR2 impairs hippocampal neurogenesis while TLR4 knockout facilitates
proliferation and neuronal differentiation (Rolls et al. 2007). Activation of the innate
immune system is also linked to CNS disease (Hanisch et al. 2008; Lehnardt 2010). Recent
studies find that alcoholism is associated with increased brain microglial markers and
expression of the proinflammatory cytokine CCL2 (MCP-1 [He and Crews 2008]) as well as
increased TLR and HMGB1 expression (Crews et al. 2013). In addition, increased
expression of neuroimmune genes is associated with depression, neurodegeneration, and
many other brain diseases (Forrest et al. 2012; Garate et al. 2013; Hanisch et al. 2008;
Maczurek et al. 2008; Suchankova et al. 2012). Signaling through RAGE can also contribute
to neuroinflammation. For instance, extracellular HMGB1 activation of RAGE contributes
to increased transcription of nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-κB) increasing expression of proinflammatory cytokines, oxidases, and other
neuroimmune genes (Han et al. 2011). Once activated in the CNS, neuroimmune signals
often remain elevated well beyond resolution of the activating event in the periphery (Qin et
al. 2008; Qin et al. 2007), which is consistent with the insidious nature of many brain
diseases. Thus, alcohol-induced changes in RAGE/TLR-HMGB1 expression may contribute
to brain disease.
Adolescence is a developmental period in humans and other mammalian species
characterized by high levels of impulsivity, thrill seeking, and risk-taking that parallels
maturation of the prefrontal cortex and executive functions. For instance, there is substantial
refinement of prefrontal synapses during adolescence, involving pruning of excitatory
glutamatergic inputs (Huttenlocher 1984) and fine-tuning of dopaminergic and serotonergic
innervations (Kalsbeek et al. 1988; Rosenberg and Lewis 1994). Unfortunately, adolescence
is also a time when the majority of young people initiate alcohol use (Windle et al. 2008),
with current statistics indicating that approximately 12% of 13-14 year old 8th graders, 22%
of 10th graders, and 28% of 12th graders report heavy episodic drinking (i.e., >5 consecutive
alcohol drinks per binge drinking episode) in the past two weeks (Masten et al. 2008;
Windle et al. 2008). Interestingly, an early age of drinking onset (i.e., <14 to 21 years of
age) is associated with 4- to 5-fold greater risk of developing alcoholism within the lifetime
and increased lifetime problems while drinking (Grant et al. 2001; Hingson et al. 2001;
Hingson et al. 2000). Thus, we tested the hypothesis that binge drinking during adolescence
alters RAGE/TLR4-HMGB1 expression that persists, and could contribute to alcoholism or
other brain diseases.
We report here that RAGE mRNA and protein expression is increased in the post-mortem
human alcoholic orbitofrontal cortex (OFC), and that an earlier age of drinking onset is
correlated with increased expression of RAGE, TLR4, and HMGB1. Using a rodent model
to determine if adolescent binge ethanol exposure contributed to these changes, we found
maturational changes in RAGE, TLR4, and HMGB1 expression in the developing rat
prefrontal cortex. Adolescent binge ethanol (5.0 g/kg, i.g. from postnatal day [P] 25 to P55)
increased RAGE expression in the young adult (P80) 25 days after the last ethanol binge,
while levels of TLR4 and HMGB1 were persistently upregulated from late adolescence
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(P56) to young adulthood (P80). Further, we found increased expression of proinflammatory
cytokines, oxidases, and neuroimmune agonists in the young adult frontal cortex. These data
support the hypothesis that adolescent binge ethanol persistently upregulated RAGE, TLR4,
HMGB1, and other neuroimmune markers that could contribute to the development of
alcoholism and other brain diseases associated with neuroinflammation.
Materials and methods
Post-mortem Human Samples
Human post-mortem paraffin sections and frozen samples of the OFC (see Figure 1A) were
obtained from the New South Wales Tissue Resource Centre at the University of Sydney,
supported by the National Health and Medical Research Council of Australia-Schizophrenia
Research Institute and the National Institute of Alcohol Abuse and Alcoholism (NIH
[NIAAA] R24AA012725). Subject information was collected through personal interviews,
next-of-kin interviews, and medical records, and is presented in Table 1. Alcoholic patients
reported an average age of drinking onset of 18±1 years of age, which were compared with
age-matched moderate drinking controls whose average age of drinking onset was 25±1.
Age of drinking onset was determined through personal interviews, medical records, and
next-of-kin interviews, or recorded as 25 years of age if the age of drinking onset was
unclear from these sources (Sheedy et al. 2008). Only individuals with alcohol dependence
uncomplicated by liver cirrhosis and/or nutritional deficiencies were included. All
psychiatric and alcohol use disorder diagnoses were confirmed using the Diagnostic
Instrument for Brain Studies that complies with the Diagnostic and Statistical Manual of
Mental Disorders (Dedova et al. 2009).
Western Blot Determination of Human RAGE Expression
For human Western blots, 70 mg of frozen OFC tissue was homogenized in 0.8 ml RIPA
lysis buffer (Sigma-Aldrich, St. Louis, MO) containing protease inhibitor (1:100; Sigma-
Aldrich) and centrifuged at 14000 rpm at 4°C for 20 min. After centrifugation, protein
content in the supernatant was assessed using a Bradford reagent kit (Bio-Rad, Hercules,
CA), and 7 μg of protein from each denatured sample was loaded into precast
polyacrylamide mini-gel (4-15%; Bio-Rad), and blotted onto immunoblot PVDF membranes
(Bio-Rad). Immunoblot membranes were blocked in Odyssey blocking buffer (LiCOR
Biosciences, Lincoln, NE), and incubated in the primary antibody solution (rabbit anti-
RAGE [1:500] and mouse anti-Tubulin [1:1000]; Abcam, Cambridge, MA) for 24 hr at 4°C.
After washing, the immunoblot membranes were incubated in appropriate fluorescent
secondary antibodies (Rockland Immunochemicals, Gilbertsville, PA), and bands were
scanned with an Odyssey Infrared Imager (LiCOR Bioscience, Lincoln, NE). Band intensity
was quantified using Bioquant Imaging software and normalized to Tubulin band intensity.
Animals
Young time-mated pregnant female Wistar rats (embryonic day 17; Harlan Sprague-Dawley,
Indianapolis, IN) were acclimated to our animal facility prior to birthing. P1 (24 hr after
birth), litters were culled to 10 pups. Dams were housed in a temperature- (20°C) and
humidity-controlled vivarium on a 12 h/12 h light/dark cycle (light onset at 700 h), and
provided ad libitum access to food and water. All experimental procedures were approved
by the Institutional Animal Care and Use Committee (IACUC) of the University of North
Carolina at Chapel Hill, and conducted in accordance with National Institute of Health
(NIH) regulations for the care and use of animals in research.
Vetreno et al. Page 3














On P21, male Wistar rats were weaned and randomly assigned to either: (i) adolescent
intermittent ethanol (AIE) or (ii) water-treated control (CON). From P25 to P55, AIE
animals received intragastric (i.g.) administration of ethanol (5.0 g/kg, 20% ethanol w/v) and
CON subjects received comparable volumes of H2O on a 2-day on/2-day off schedule
(Figure 1B). Body weight (g) was measured for the duration of experimentation. Tail blood
was collected to assess blood ethanol content (BEC) one hour after ethanol administration
on P38 and P54. Tail BECs were calculated using a GM7 Analyzer (Analox; London, UK).
On P38 and P54, mean BECs (±SEM) were 134±8 mg/dL and 165±17 mg/dL, respectively.
For the duration of experimentation, subjects evidenced dramatic increases in body weight
that were not significantly affected by AIE treatment (all p’s>0.1 [P25: CON=80±1 g,
AIE=80±2 g; P55: CON=306±8 g; AIE=290±5 g; P80: CON=428±14 g; AIE=427±14 g]).
Immunohistochemistry
Human post-mortem paraffin sections were deparaffinized, washed in TBS, and antigen
retrieval performed by incubation in Citra solution (BioGenex, San Ramon, CA) for 1 hr at
70°C. Following incubation in blocking solution with normal goat serum (MP Biomedicals,
Solon, OH), slides were processed in primary antibody solution (rabbit anti-RAGE [1:500];
Abcam) for 24 hr at 4°C. Slides were incubated for 1 hr in biotinylated secondary antibody
(1:200; Vector Laboratories, Burlingame, CA), and then incubated for 1 hr in avidin-biotin
complex solution (Vectastain ABC Kit; Vector Laboratories). The chromogen, nickel-
enhanced 3,3′-diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich, St. Louis, MO),
was used to visualize immunoreactivity. Slides were dehydrated and coverslipped. Negative
control for non-specific binding was conducted on separate sections employing the above-
mentioned procedures with the exception that the primary antibody was omitted.
On P56 and P80, male Wistar rats were anesthetized with sodium pentobarbital (100 mg/kg,
i.p.) and transcardially perfused with 0.1 M phosphate-buffered saline (PBS, pH 7.4),
followed by 4.0% paraformaldehyde in PBS. Coronal section (40 μm) were cut on a sliding
microtome (MICROM HM450; ThermoScientific, Austin, TX), and sections were
sequentially collected into well plates and stored at −20°C in a cryoprotectant solution (30%
glycol/30% ethylene glycol in PBS) for immunohistochemistry. Free-floating frontal cortex
sections were processed similar to previously described methods (Vetreno and Crews 2012).
Sections were incubated in primary antibody (rabbit anti-RAGE [1:1000], rabbit anti-TLR4
[1:200], or rabbit anti-HMGB1 [1:500]; Abcam) for 24 hr at 4°C. Slides were then rinsed in
TBS, and processed identically to the previously described methodology.
Microscopic Quantification and Image Analysis
In the human study, eight regions of interest within the OFC were randomly assessed for
RAGE immunoreactivity (+IR). In the animal studies, assessment of RAGE +IR was
performed in the PrL (Bregma: +4.70 mm to +2.20 mm), IL (Bregma: +3.20 mm to +2.20
mm), and OFC (Bregma: +4.70 mm to +2.20 mm) according to the atlas of Paxinos and
Watson (1998). For all animal immunohistochemical protocols, sections were assessed in a
1:6 series containing the PFC (see Figure 1C). In each cortical region, +IR was assessed in 4
randomly selected regions of interest per hemisphere, for a total of 8 samples per section.
Across experiments, BioQuant Nova Advanced Image Analysis (R&M Biometric,
Nashville, TN) was used for image capture and quantification. Representative images were
captured using an Olympus BX50 microscope and Sony DXC-390 video camera linked to a
computer. Since RAGE expression was dense and homogenously distributed throughout the
rodent tissue samples, pixel density was used to quantify RAGE+IR within the region of
interest and thresholded to normalize pixel intensity. The outlined region of interest was
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determined and staining density calculated by dividing the pixel count by the overall area
(mm2). In contrast to RAGE, TLR4 and HMGB1+IR was heterogeneous, and quantification
was performed using a modified stereological profile cell counting method within the
regions of interest (Crews et al. 2004; Vetreno and Crews 2012), and data are expressed as
cells per mm2. In the human experiments, RAGE+IR was quantified similarly to the
protocol described above. For each measure, the microscope, camera, and software were
background corrected and normalized to preset light levels to ensure fidelity of data
acquisition.
Double Immunofluorescence and Confocal Analysis
To determine co-expression of RAGE with NeuN in the human OFC, post-mortem paraffin-
embedded sections were washed in TBS, incubated in 0.3% H2O2, antigen retrieval
performed by incubation in Citra solution (BioGenex), and blocked with normal horse serum
(MP Biomedicals). Slides were incubated for 48 hr at 4°C in a primary antibody cocktail of
rabbit anti-RAGE (1:1000; Abcam) with an antibody against neurons (mouse anti-NeuN
[1:500; Millipore, Temecula, CA]). Slides were then rinsed in TBS and incubated for 2 hr at
room temperature in the secondary antibody cocktail (Alexa Fluor 594 and Alexa Fluor 488;
Invitrogen, Carlsbad, CA). Slides were coverslipped using Prolong Gold Anti-fade mounting
media (Life Technologies, Grand Island, NY).
Free-floating frontal cortex sections from P80 rats were processed similar to previously
reported methods (see Vetreno and Crews 2012). Briefly, sections were incubated for 48 hr
at 4°C in a primary antibody cocktail of rabbit anti-RAGE (1:1000; Abcam) with an
antibody against neurons (mouse anti-NeuN [1:500; Millipore]), microglia (1:1000 goat
anti-Iba-1 [Abcam]), or astrocytes (1:1000 goat anti-GFAP [Abcam]). Sections were washed
in TBS, and processed identically to the previously described immunofluorescence
methodology. Confocal analysis was performed using an inverted Zeiss 510 Meta laser
scanning confocal microscope (Carl Zeiss MicroImaging, Thomwood, NY) in the Michael
Hooker microscopy facility at UNC equipped with standard high-power objectives and
corresponding software (LSM 510 META). Single optical Z-stacks (1 μm; 1-airy unit) were
collected, and the number of RAGE cells that co-localized with NeuN were counted
(approximately 100 RAGE+IR cells per subject).
RNA Extraction and Reverse Transcription Polymerase Chain Reaction
For human analysis, RNA was extracted from frozen OFC tissue by homogenization in
TRIzol (Invitrogen). Tissue samples from the rat were collected anterior of the union of the
corpus callosum (approximately +1.60 mm from Bregma) according to the atlas of Paxinos
and Watson (1998), and reverse transcribed as previously described (see Vetreno and Crews
2012; Zou et al. 2012). The primer sequences are presented in Table 2. Differences in primer
expression between groups were expressed as cycle time (Ct) values normalized with β-
actin, and relative differences between groups were calculated and expressed as the percent
difference relative to CONs.
Statistical Analysis
Statistical analysis was performed using SPSS (Chicago, IL). Analysis of variance
(ANOVA) was used to determine the effects of AIE on BEC, immunohistochemistry,
Western blot protein analysis, and real time PCR mRNA expression. Repeated measure
ANOVAs were used to assess the effects of AIE on body weight. Pearson’s r correlations
were used to determine the association between neuroimmune receptor (i.e., RAGE and
TLR4) and HMGB1 expression in the animal experiment, and neuroimmune expression
(i.e., RAGE, TLR4, and HMGB1) with age of drinking onset in the human experiment. All
values are reported as mean ± SEM, and significance was defined at p≤0.05.
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RAGE is Elevated in the Post-mortem Human Alcoholic Orbitofrontal Cortex
To determine if RAGE expression was increased in the human alcoholic OFC, we
performed immunohistochemistry, Western blot, and RT-PCR analysis. In moderate
drinking controls, RAGE+IR was characterized by lightly stained large and small cells,
whereas RAGE+IR in the alcoholic was characterized by darkly stained large, neuron-like
cells and smaller glia-like cells. Microscopic quantification found an approximate 2-fold
increase in RAGE+IR (196%±36%) in the alcoholic OFC, relative to moderate drinking
controls (one-way ANOVA: F=4.7, p<0.05 [see Figure 2A]). Similar to the
immunohistochemical data, Western blot analysis of RAGE protein expression found a
176%±29% increase in the human alcoholic OFC, relative to moderate drinking controls
(one-way ANOVA: F=5.5, p<0.05, see Figure 2B). Further, expression of RAGE mRNA
was increased by 161%±24% in the human post-mortem alcoholic OFC (one-way ANOVA:
F=5.5, p<0.05, see Figure 2C). Given our findings of increased RAGE expression, we used
confocal microscopy to assess co-expression of RAGE on neurons, and found that 77%±9%
of RAGE+IR colocalized with NeuN-positive neurons in the human OFC (see Figure 2D).
Thus, we find increased RAGE mRNA and protein (+IR and Western analysis) in the human
post-mortem alcoholic OFC that is primarily localized on neurons.
Expression of RAGE, TLR4, and HMGB1 Correlates with Age of Drinking Onset in Humans
Since an earlier age of drinking onset is associated with increased risk of alcohol
dependence across the lifetime of the individual (Grant and Dawson 1998; Gruber et al.
1996), we correlated age of drinking onset with expression of RAGE, TLR4, and HMGB1.
Age of drinking onset was negatively correlated with expression of RAGE (r=-0.52, p<0.05,
n=20), TLR4 (r=-0.66, p<0.01, n=20), and HMGB1 (r=-0.72, p<0.01, n=20) in the human
post-mortem OFC. As depicted in Figure 3, a younger age of drinking onset is associated
with increased expression of RAGE, TLR4, and HMGB1, with extremely high levels of
RAGE expression only found in alcoholics that reported an earlier age of drinking onset
(18±1). Since establishing an accurate age of drinking onset is important for this analysis,
trained clinical nurses and psychologists from the New South Wales Tissue Resource Centre
performs extensive interviews with human study volunteers and their families when
volunteers indicate that they will become post-mortem brain donors. The age of drinking
onset is derived from personal interviews with the volunteer as well as medical records and
next-of-kin interviews. In cases where the age of drinking onset was not recalled or unclear,
an age of 25 was given (Sheedy et al. 2008). It is possible that individuals who could not
recall the age they began drinking impacted this correlation, so we removed those assigned
an age of 25. However, we found that age of drinking onset was still negatively correlated
with neuroimmune signal expression in the post-mortem human OFC (r=-0.34, p=0.05,
n=33). It is interesting to note that 90% of alcoholics were able to recall the age at which
drinking commenced while only 20% of moderate drinking controls were able to provide
accurate drinking age onset. Thus, the expression of RAGE, TLR4, and HMGB1 in the
OFC, either independently or grouped, show a significant correlation with age of drinking
onset.
Adolescent Intermittent Ethanol Exposure Disrupts the Maturational Trajectory of RAGE
Expression in the Young Adult Rat Prefrontal Cortex
The association of RAGE induction with age of drinking onset prompted investigation of the
effect of ethanol during adolescence on expression of RAGE. We modeled adolescent
drinking using an intermittent schedule that is consistent with known human adolescent
patterns of heavy binge drinking on weekends, but not daily drinking observed in alcoholic
adults. In our AIE model, male Wistar rats were treated intermittently with ethanol (5.0 g/
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kg, i.g., 20% ethanol w/v; 2-day on/2-day off) throughout adolescence (i.e., P25 – P55).
Receptor for advanced glycation end product expression was determined
immunohistochemically in medial prefrontal cortex sections (i.e., PrL and IL) and the OFC
of adolescent (P56) rats one day after the conclusion of AIE and 25 days after treatment in
young adulthood (P80). Assessment of RAGE+IR cells in CON- and AIE-treated adolescent
prefrontal cortex revealed widespread homogeneous distribution, characterized by darkly
stained nuclei and hollow neuron-like silhouettes (see Figure 4D). In CON animals, we
found a significant age-associated maturational decline of RAGE+IR from adolescence
(P56) to young adulthood (P80) in the PrL (85%; one-way ANOVA: F=73.0, p<0.01), IL
(70%; one-way ANOVA: F=40.9, p<0.01), and OFC (84%; one-way ANOVA: F=60.7,
p<0.01). Adolescent binge ethanol exposure did not affect RAGE+IR in the adolescent PrL,
IL, or OFC relative to the CON subjects (all p’s>0.1). In young adulthood (P80), AIE
increased RAGE+IR by 280%±36% in the PrL (one-way ANOVA: F=43.3, p<0.01), 375%
±80% in the IL (one-way ANOVA: F=22.0, p<0.01), and 340%±36% in the OFC (one-way
ANOVA: F=65.3, p<0.01), relative to CONs (see Figure 4A-4C). Measures of RAGE
mRNA in young adult (P80) frontal cortex tissue samples from AIE-treated animals did not
reveal any differences relative to CONs (data not shown). Together, these data suggest that
RAGE expression in the developing adolescent prefrontal cortex undergoes an age-
associated maturational decline that is reduced by adolescent binge ethanol exposure,
resulting in increased expression in the young adult OFC.
To determine the cellular phenotype of cells expressing RAGE in the young adult prefrontal
cortex (P80), we used double immunofluorescence to assess colocalization of RAGE with
NeuN (a neuronal marker), Iba-1 (a microglial marker), and GFAP (an astrocyte marker).
Employing confocal microscopy, we found that 96%±3% and 89%±2% of RAGE+IR
colocalized with NeuN (one-way ANOVA: F=12.7, p<0.05) in the CON- and AIE-treated
prefrontal cortex (i.e., PrL, IL, and OFC), respectively. Assessment of Iba-1 yielded very
low levels of colocalization in either treatment group. In contrast, we found that 5%±0.3%
and 8%±2% of RAGE-immunopositive cells colocalized with the astrocytic marker GFAP
(p>0.05) in CON- and AIE-treated animals, respectively (see Figures 5A and 5B). Thus,
similar to the human OFC, the majority of RAGE+IR is colocalized in neurons (NeuN+IR)
in the rat prefrontal cortex.
Binge Ethanol Exposure During Adolescence Persistently Increases TLR4 and HMGB1
Expression in the Young Adult Orbitofrontal Cortex
Our findings in human OFC prompted investigation of how RAGE induction by AIE relates
to expression of TLR4+IR and HMGB1+IR in the rat OFC. Expression profiles of TLR4-
positive cells in CONs during adolescence (P56) was characterized by distinct hollow
neuron-like silhouettes that declined significantly with age from P56 to P80 (one-way
ANOVA: F=529.7, p<0.01). Assessment of AIE-treated rats revealed more TLR4+IR cells
(see Figure 6B). Adolescent binge ethanol exposure increased TLR4+IR by 32%±2% in the
adolescent at P56 (one-way ANOVA: F=106.3, p<0.01) and 141%±40% in the young adult
OFC at P80 (one-way ANOVA: F=11.5, p<0.01), relative to CONs (see Figure 6A). Across
treatment and age, HMGB1+IR cells were homogeneously expressed, appearing as solid
nuclei and hollow somas (see Figure 7B). In CONs, we found increased HMGB1+IR in
young adult (P80) OFC relative to adolescents (P56 [one-way ANOVA: F=18.1, p<0.01]).
Quantification of HMGB1+IR in the AIE-treated animals revealed significantly increased
HMGB1+IR cells in the adolescent OFC (41%±5% [one-way ANOVA: F=80.1, p<0.01])
that persisted into young adulthood (61%±7% [one-way ANOVA: F=69.1, p<0.01]), relative
to CONs (see Figure 7A). Together, these data support the hypothesis that AIE treatment of
rats increases RAGE, TLR4, and HMGB1+IR in the young adult OFC.
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Previous studies have hypothesized that positive loops of activation underlie neuroimmune
gene induction (Crews et al. 2011). This hypothesis would predict a relationship between
RAGE and HMGB1 expression in the prefrontal cortex. In AIE-treated rats, expression of
HMGB1 was correlated with RAGE in the young adult prefrontal cortex (see Table 3).
Interestingly, the strongest correlation of HMGB1 with RAGE was in the OFC, although all
brain regions measures showed positive correlations. These findings are consistent with
RAGE-HMGB1 upregulation contributing to their own induction as well as the
amplification and persistence of neuroimmune expression in brain.
Adolescent Binge Ethanol Upregulates Downstream Cytokine, Oxidase, and Neuroimmune
Agonist Expression in the Young Adult Prefrontal Cortex
Since HMGB1 is an agonist at RAGE and TLR4 that converge upon NF-κB transcription of
innate immune genes, we assessed expression of proinflammatory cytokines, oxidases, and
other innate immune genes in the young adult frontal cortex (P80) 25 days after the last
binge ethanol exposure. Assessment of cytokine mRNA revealed an AIE-induced increase
of TNFα (one-way ANOVA: F=25.3, p<0.01) and MCP-1 (one-way ANOVA: F=58.3,
p<0.01) by approximately three-fold, but did not change expression of IL-1β (p>0.2),
relative to CONs (see Figure 8A). Measures of proinflammatory oxidase mRNA revealed an
approximate three-fold increase of NOX2 (one-way ANOVA: F=62.2, p<0.01) and a two-
fold increase in COX2 (one-way ANOVA: F=6.7, p<0.05), relative to CONs. Levels of
iNOS were unchanged in the young adult frontal cortex following AIE exposure (p>0.4 [see
Figure 8B]). Measurement of neuroimmune signaling molecule mRNA found a two-fold
increase of fibronectin (one-way ANOVA: F=42.4, p<0.01) and an 80% increase of S100β
(one-way ANOVA: F=7.5, p<0.05) in the young adult frontal cortex, relative to CONs.
Assessment of MyD88, a downstream adaptor protein of the proinflammatory TLR4 and
RAGE cascade, found a 44% increase relative to CONs (one-way ANOVA: F=6.2, p<0.05
[see Figure 8C]). These data indicate that AIE exposure increases neuroimmune gene
mRNA consistent with increased RAGE/TLR4-HMGB1 expression inducing innate immune
gene upregulation in the prefrontal cortex.
Discussion
We report here for the first time that RAGE is upregulated in the post-mortem human
alcoholic OFC, and an earlier age of drinking onset is correlated with increased RAGE,
TLR4, and HMGB1 expression. The association between an early age of drinking onset and
increased expression of RAGE, TLR4, and HMGB1 in the human OFC prompted
investigation into the persistence of ethanol-induced neuroimmune upregulation in an
animal model of adolescent binge drinking. From adolescence to young adulthood, we
observed a maturational shift in neuroimmune expression, with levels of RAGE and TLR4
decreasing while HMGB1 increased, in the rat prefrontal cortex. Adolescent binge ethanol
in rats produced a maturational shift in prefrontal cortex RAGE expression culminating in
increased levels by young adulthood, while AIE upregulated TLR4 and HMGB1 in the
adolescent that persisted into young adulthood. The persistence of RAGE, TLR4, and
HMGB1 in the rat prefrontal cortex may be due in part to activation of proinflammatory
positive loops as evidenced by increased expression of proinflammatory cytokines (i.e.,
TNFα and MCP-1), oxidases (COX2 and NOX2), and innate immune agonists (i.e.,
HMGB1, S100ß, and fibronectin). Together, these data support the hypothesis that
adolescent binge drinking persistently upregulates neuroimmune gene expression in the
prefrontal cortex that might contribute to the development of alcohol dependence and other
brain diseases.
While the mechanisms underlying ethanol induction of neuroimmune genes are complex,
the correlation of AIE-induced RAGE and TLR4 upregulation (Vetreno and Crews 2012)
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with HMGB1 is consistent with these molecules signaling through positive loops of
amplification that increase neuroimmune gene expression (see Figure 9A). Although we
found an AIE-induced increase of HMGB1expression in the adult OFC and medial
prefrontal cortex (Vetreno and Crews 2012), the subcellular distribution of upregulated
HMGB1 is not clear. Previous studies using monocytes (Bonaldi et al. 2003) and
hepatocytes (Evankovich et al. 2010) suggest that HMGB1 cycles between nuclear and
cytosolic forms with cell activation releasing cytosolic forms from vesicles. In the present
study, we investigated HMGB1 distribution in brain cells, but do not feel we can determine
nuclear vs. cytosolic distribution reliably from our immunohistochemistry. Regardless, we
previously found increased HMGB1 protein expression in both cell lysate and the media
derived from hippocampal brain slice culture exposed to ethanol (Crews et al. 2013),
supporting that HMGB1 is released from cells exposed to ethanol. Increased NF-κB
transcription of proinflammatory signaling includes TLR4 and RAGE genes that are induced
during proinflammatory cascades (Rouhiainen et al. 2013; Tewari et al. 2012). We have
previously reported that ethanol treatment increases brain HMGB1 and TLR4 mRNA,
indicating that gene induction occurs during ethanol treatment. Chronic alcohol exposure
has previously been found to increase NF-κB-DNA binding as well as increased expression
of proinflammatory target genes, such as TNFα, IL-1β, NOX, and iNOS (Crews et al. 2013;
Crews and Vetreno 2011; Qin and Crews 2012; Vetreno and Crews 2012; Zou and Crews
2012). In addition to HMGB1, adolescent binge ethanol exposure leads to long-term
upregulation of other innate immune receptor agonists, such as S100B and fibronectin,
which are agonists at RAGE (Han et al. 2011) and TLR4 (Ribes et al. 2010), respectively.
The induction of TLR4-HMGB1 protein persists into adulthood during long periods of
abstinence, which are consistent with persistently increased signaling. Receptor for
advanced glycation end product expression was not increased during ethanol treatment, but
increased during the abstinent maturation period into young adulthood. Upregulation of
RAGE is induced by NF-κB, consistent with TLR4-HMGB1 signaling leading to persistent
and progressive changes in RAGE. Thus, it is possible that RAGE upregulation occurs
downstream of TLR4-HMGB1 signaling.
The innate immune system is activated in alcoholism and alcohol dependence is associated
with an earlier age of drinking onset. Receptor for advanced glycation end products is well
known to be induced during innate immune activation (Rouhiainen et al. 2013). In the
human alcoholic, we found increased RAGE mRNA and protein expression in the OFC.
Similar to our human data, chronic ethanol exposure in young adult mice (i.e., 5 months)
resulted in elevated levels of RAGE in the cerebellum (Lippai et al. 2013). These results are
consistent with previous work from our laboratory that found activated microglia as well as
upregulated expression of MCP-1, TLR4, and HMGB1 in the post-mortem human alcoholic
brain (Crews et al. 2013; He and Crews 2008). In addition to alcoholics, RAGE expression
was found to increase in the human Parkinsonian substantia nigra (Sathe et al. 2012) as well
as in the temporal lobe of patients with epilepsy (Iori et al. 2013; Zurolo et al. 2011). In the
present study, our observation that an earlier age of drinking onset in humans (i.e., during
early adolescence) correlated with increased RAGE, TLR4, and HMGB1 expression may
represent a mechanism contributing to the increased risk for alcohol dependence in
individuals that start drinking at an younger age (Grant 1998). Adolescence is a period of
considerable prefrontal cortex maturation involving fine-tuning of afferent and efferent
projections, and refinement of neurotransmitter systems to adult levels (Ernst et al. 2009;
Spear 2000). Initiation of alcohol use typically commences during adolescence (Johnston et
al. 2009), and adolescent individuals are capable of binge drinking because they are less
sensitive to the sedative effects of alcohol (Silveri and Spear 1998). As a consequence of
binge drinking and higher blood alcohol contents, there is a greater risk of alcohol-induced
neurotoxicity (Crews et al. 2007; Monti et al. 2005) and activation of the innate immune
system in the brain that may alter adolescent-typical cortical maturation. Once activated, the
Vetreno et al. Page 9













innate immune system remains elevated for long periods in the CNS (Qin et al. 2008; Qin et
al. 2007), and may contribute to the risk of later alcohol dependence. Although we found a
correlation between age of drinking onset and neuroimmune expression in the human
alcoholic OFC, previous studies also found a correlation between neuroimmune signal
expression and lifetime alcohol consumption (Crews et al. 2013). Thus, our findings indicate
that adolescent exposure can induce long-term changes in adult brain, but do not establish
the adolescent brain response as unique since adult chronic ethanol treatment also induces
neuroimmune genes (Crews et al. 2011). However, this is the first study to report an effect
of ethanol on RAGE expression. The AIE model was designed to replicate human
adolescent drinking patterns that involve heavy binge drinking on weekends (i.e.,
intermittent, high levels of exposure), which is not common in adult human alcoholics.
Additional studies are needed to determine whether chronic ethanol induces RAGE in adult
rats, but we found that RAGE expression is increased in the adult alcoholic human brain.
The human and rodent data in the present study support the hypothesis that adolescent binge
drinking is capable of persistently upregulating neuroimmune expression, which might
contribute to increased drinking later in life. In support of this hypothesis, a previous study
found that binge ethanol exposure during early adolescence (i.e., P30 to P43) increased
ethanol consumption later in life while late adolescent exposure (i.e., P45 to P58) did not
impact adult drinking behavior (Alaux-Cantin et al. 2013). Further, in a series of elegant
studies, Blednov and colleagues provide compelling evidence supporting the hypothesis that
innate immune genes regulate ethanol drinking. Across multiple strains of transgenic mice
with innate immune gene deletions, these animals universally drink significantly less ethanol
than matched controls across multiple ethanol drinking paradigms (Blednov et al. 2005;
Blednov et al. 2012). In further support, activation of the innate immune system with
lipopolysaccharide, the prototypical TLR4 agonist, induced long-lasting increases in ethanol
consumption in mice (Blednov et al. 2011). Thus, the increased vulnerability of the
adolescent brain to alcohol-induced neurotoxicity and neuroimmune gene induction might
contribute to the development of alcohol dependence.
Although we are beginning to unravel the effects of ethanol exposure on neuroimmune
signaling in the adult brain, little is known regarding the consequences of ethanol-induced
activation of the innate immune signaling system during adolescent maturation. This is of
particular import given the potential involvement of TLR4 and RAGE in the maturation of
the adolescent prefrontal cortex as well as the quantities of alcohol consumed by adolescents
during this period (Deas et al. 2000). In the rat, we found that levels of RAGE
immunoreactivity were unchanged 24 hours following the conclusion of AIE treatment, but
after an extended period of abstinence, RAGE was increased in the young adult prefrontal
cortex. In contract, TLR4 and HMGB1 expression was increased at the conclusion of
adolescent binge ethanol exposure (P56) and remained elevated into young adulthood (P80),
an effect that was previously observed in the medical prefrontal cortex (Vetreno and Crews
2012). Although the mechanisms underlying the delay in RAGE upregulation are unknown,
it might involve an ethanol-induced maturational shift in RAGE expression. It is also
possible that RAGE upregulation occurs downstream of TLR4-HMGB1 signaling.
Consistent with our animal findings, increased RAGE expression is delayed in a mouse
model of Parkinson’s disease (Sathe et al. 2012). Interestingly, we found that the majority of
RAGE immunoreactivity colocalized with NeuN-positive neurons in both the post-mortem
human OFC and in the young adult rat prefrontal cortex. In other studies, RAGE expression
was predominantly observed on neurons (Iori et al. 2013; Zurolo et al. 2011), with some
increase in astrocytic colocalization (Iori et al. 2013), which complements our human and
animal data. The increase in neuronal RAGE may lead to hyperexcitability (Iori et al. 2013)
resulting in frontal cortical deactivation (Crews et al. 2006) and consequent behavioral
inflexibility (Gruber et al. 2010). Thus, adolescent binge ethanol induction of the innate
immune system may contribute to increased risk of alcohol dependence through
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hyperexcitability-induced diminution of cortical behavioral control and behavioral
inflexibility.
Involvement of the innate immune system in adolescent maturation has not been explored,
but work in the embryonic brain implicates both RAGE and TLRs in neural development.
During brain development, RAGE modulates neuronal development and neurite outgrowth
(Wang et al. 2008) via interactions with HMGB1 (amphoterin) and S100B (Huttunen et al.
1999; Huttunen et al. 2000). Similarly, TLR signaling exerts a neuromodulatory role in
neural development, neurogenesis, and neurite outgrowth (Fang et al. 2012; Trudler et al.
2010). Given the involvement of these receptors in brain development, RAGE and TLR4
might also contribute to maturation of the prefrontal cortex during adolescence. In CON
subjects, we found a maturational reduction of RAGE- and TLR4-immunopositive cells as
the adolescent (P56) transitioned to young adulthood (P80). These data also suggest that
RAGE and TLR4 might undergo age-associated pruning similar to neurotransmitter receptor
diminution that occurs between adolescence and adulthood (see e.g., Coleman et al. 2011).
In contrast, we found that HMGB1 expression in CONs increased in an age-dependent
manner from adolescence (P56) to young adulthood (P80). HMGB1 has been shown to exert
its physiological effects through interactions with RAGE and TLR4 to modulate neurite
outgrowth and neurogenesis (see e.g., Huttunen et al. 1999). Taken together, these data
indicate that these pathways might play an important physiological role in neuroplasticity
and/or neurodevelopment, and highlight the need to further elucidate the involvement of the
innate immune signaling system in brain development and maturation.
In conclusion, RAGE expression is increased in the human post-mortem alcoholic OFC, and
importantly, humans that started drinking at an earlier age had the highest expression of
RAGE, TLR4, and HMGB1 (see Figure 9B). Using a rat model of adolescent binge
drinking, we observed developmental changes in neuroimmune expression, with RAGE and
TLR4 levels reducing with age while HMGB1 levels increased in the prefrontal cortex.
These novel data suggest that the observed developmental changes in RAGE, TLR4, and
HMGB1 expression might reflect maturational changes in the prefrontal cortex. We found
that adolescent binge ethanol persistently alters expression of TLR4 and HMGB1, whereas
RAGE expression only changed later in development suggesting that ethanol might alter the
maturational reductions in RAGE expression (see Figure 9C). These data reveal that early
life insults exert long-lasting neuroimmune changes in the developing CNS that might
contribute to increased risk of developing alcohol dependence and other psychopathologies.
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• RAGE expression is increased in human post-mortem alcoholic orbitofrontal
cortex
• RAGE, TLR4, and HMGB1 induction correlates with human age of drinking
onset
• Adolescent binge ethanol leads to a maturational increase in adult RAGE
expression
• Adolescent binge ethanol persistently upregulates neuroimmune receptors in
brain
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FIGURE 1. SAMPLE SELECTION AND EXPERIMENTAL DESIGN
(A) Representative image depicting human orbitofrontal cortex (OFC) sectioning by New
South Wales Tissue Resource Centre at the University of Sydney. Left: Image of intact
alcoholic frontal cortex tissue sample containing OFC. Right: Image depicting sampling of
OFC from alcoholic volunteer. Scale bar = 1 cm. (B) Male Wistar rats were treated from
postnatal day (P)25 to P55 with either ethanol (5.0 g/kg, 20% ethanol w/v, i.g.) or a
comparable volume of water on a 2-day on/2-day off administration schedule. Blood ethanol
concentrations (BECs) were measured one hr after ethanol treatment on P38 and P54.
Subjects were sacrificed either 24 hr after the completion of AIE treatment (i.e., P56) or 25
days after the conclusion of AIE treatment (i.e., P80). (C) Representative micrographs of the
regions of interest assessed for neuroimmune agonist and receptor expression in the
prefrontal cortex. Receptor for advanced glycation end product expression was measured in
subregions of the rat medial prefrontal cortex (mPFC), including the prelimbic cortex (PrL;
Bregma: +4.20 mm to +2.20 mm) and infralimbic cortex (IL; Bregma: +3.20 mm to +2.20
mm) as well as the orbitofrontal cortex (OFC; Bregma: +4.20 mm to +2.20 mm) according
to the atlas of Paxinos and Watson (1998). Toll-like receptor 4 and high-mobility group box
1 immunoreactivity was measured in the OFC (Bregma: +4.20 mm to +2.20 mm) according
to the atlas of Paxinos and Watson (1998).
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FIGURE 2. RECEPTOR FOR ADVANCED GLYCATION END PRODUCT (RAGE)
EXPRESSION IS INCREASED IN THE HUMAN POST-MORTEM ORBITOFRONTAL
CORTEX (OFC) AND IS COLOCALIZED ON NEURONS
(A) RAGE pixel density (×1000 Pixels/mm2) was increased in the alcoholic OFC (n=10),
relative to moderate drinking controls (n=10). Representative photomicrographs of RAGE
+IR in a moderate drinking control and alcoholic post-mortem OFC. Scale bar = 20 μm. (B)
Western blot analyses found increased RAGE protein concentration in the human alcoholic
OFC, relative to moderate drinking controls (n=9). Representative lanes from Western blot
analysis of RAGE. CON is moderate drinking control and ALC alcoholic subject. Western
blot analyses were run in triplicate, and the mean was reported. (C) RT-PCR assessment
found increased RAGE mRNA in the human alcoholic OFC, relative to moderate drinking
controls (n=8). RT-PCR analyses were run in triplicate, and the mean was reported. (D) Top
and Middle: High magnification photomicrographs of RAGE (green) colocalization with the
neuronal marker NeuN (red) in the post-mortem human alcoholic OFC. White arrowheads
indicate a RAGE+IR cell that colocalized with NeuN. Bottom: Z-stack demonstrating
colocalization of RAGE+IR cell with NeuN (yellow). Scale bar = 20 μm. * indicates p<0.05.
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FIGURE 3. RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS (RAGE), TOLL-
LIKE RECEPTOR 4 (TLR4), AND HIGH-MOBILITY GROUP BOX 1 (HMGB1)
EXPRESSION IN THE HUMAN ALCOHOLIC POST-MORTEM ORBITOFRONTAL
CORTEX IS CORRELATED WITH AGE OF DRINKING ONSET
Depicted are individual self and family reports of age of drinking onset vs. RAGE (circle; ×
100000 Pixels/mm2), TLR4 (square; Cells/mm3), and HMGB1 (triangle; Cells/mm3)
immunoreactivity. Across subjects, age of drinking onset negatively correlated with
neuroimmune immunoreactivity (r = −0.47, p<0.001). Note: Each subject’s
immunoreactivity data (i.e., RAGE, TLR4, and HMGB1) lie on vertical points over each
subject’s reported age of drinking onset. Moderate alcohol drinking controls tended to self-
report a later age of drinking onset (25±1 years of age) in comparison to individuals that met
criteria for alcoholism (18±1 years of age).
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FIGURE 4. THE MATURATIONAL TRAJECTORY OF RECEPTOR FOR ADVANCED
GLYCATION END PRODUCTS (RAGE) EXPRESSION IN THE YOUNG ADULT
PREFRONTAL CORTEX IS DISRUPTED FOLLOWING ADOLESCENT BINGE ETHANOL
EXPOSURE IN THE RAT
(A) RAGE pixel density (×1000 Pixels/mm2) was unchanged in the adolescent prelimbic
cortex (PrL) following adolescent intermittent ethanol (AIE) treatment, but was increased by
280% in the young adult, relative to CONs. (B) AIE treatment did not affect RAGE+IR in
the adolescent infralimbic cortex (IL), but did increase expression by 375% in the young
adult, relative to CONs. (C) AIE did not affect RAGE pixel density (×1000 Pixels/mm2) in
the adolescent orbitofrontal cortex, but did increase RAGE+IR by 340% in the young adult,
relative to CONs. Note: There is a maturational reduction of RAGE+IR in the CON PrL, IL,
and OFC from adolescence to young adulthood. (D) Representative photomicrographs of
RAGE+IR in the OFC of adolescent (P56) and young adult (P80) CON- and AIE-treated
rats. Black arrowheads indicate RAGE+IR cells. Data are presented as mean ± SEM. **
indicates p<0.01, relative to CON rats. Scale bar = 50 μm.
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FIGURE 5. EXPRESSION OF RECEPTOR FOR ADVANCED GLYCATION END
PRODUCTS (RAGE) IS HIGHLY COLOCALIZED WITH NEURONS IN THE RODENT
YOUNG ADULT PREFRONTAL CORTEX
(A) Quantification of RAGE colocalization with neuronal (NeuN), microglial (Iba-1), and
astrocytic (GFAP) markers. Data are presented as mean ± SEM. * indicates p<0.05, relative
to CON rats. (B) High magnification photomicrographs of RAGE (green) colocalization
with the cellular marker NeuN, Iba-1, or GFAP (red) in the prefrontal cortex of young adult
CON- and AIE-treated rats. White arrowheads indicate RAGE+IR cells that colocalized
with a cellular marker (yellow). White arrows emphasize cell makers that did not colocalize
with RAGE. All scale bars = 20 μm.
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FIGURE 6. ADOLESCENT INTERMITTENT ETHANOL (AIE) TREATMENT
PERSISTENTLY INCREASED EXPRESSION OF TOLL-LIKE RECEPTOR 4 (TLR4) IN
THE ADOLESCENT (P56) AND ADULT (P80) ORBITOFRONTAL CORTEX
(A) Profile counts (Cells/mm2) revealed that AIE exposure increased TLR4+IR cells by
32% in the adolescent and 141% in the young adult orbitofrontal cortex (OFC), relative to
CONs. Note: There is a maturational reduction of TLR4+IR in the CON OFC from
adolescence to young adulthood. ** indicates p<0.01, relative to CON rats. Scale bar = 50
μm. (B) Representative photomicrographs of TLR4+IR in OFC of adolescent (P56) and
young adult (P80) CON- and AIE-treated rats. Black arrowheads indicate TLR4+IR cells.
Data are presented as mean ± SEM. ** indicates p<0.01, relative to CON rats. Scale bar =
50 μm.
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FIGURE 7. ADOLESCENT INTERMITTENT ETHANOL (AIE) EXPOSURE INCREASES
HIGH-MOBILITY GROUP BOX 1 (HMGB1) EXPRESSION IN THE ADOLESCENT (P56)
ORBITOFRONTAL CORTEX THAT PERSISTS INTO YOUNG ADULTHOOD (P80)
(A) Profile counts (Cells/mm2) revealed that AIE treatment increased HMGB1+IR by 41%
in the adolescent and 61% in the young adult orbitofrontal cortex (OFC), relative to CONs.
Note: There is a maturational increase of HMGB1+IR in the CON OFC from adolescence to
young adulthood. ** indicates p<0.01, relative to CON rats. Scale bar = 50 μm. (B)
Representative photomicrographs of HMGB1+IR in OFC of adolescent (P56) and young
adult (P80) CON- and AIE-treated rats. Black arrowheads indicate HMGB1+IR cells. Data
are presented as mean ± SEM. ** indicates p<0.01, relative to CON rats. Scale bar = 50 μm.
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FIGURE 8. ADOLESCENT INTERMITTENT ETHANOL (AIE) EXPOSURE INCREASES
MRNA LEVELS OF PROINFLAMMATORY CYTOKINES, OXIDASES, AND
NEUROIMMUNE AGONIST MARKERS IN THE YOUNG ADULT FRONTAL CORTEX
(A) RT-PCR assessment of proinflammatory cytokine mRNA in frontal cortex tissue
samples found an approximate three-fold increase of tumor necrosis factor α (TNFα), no
change in Interleukin-1β (IL-1β), and an approximate three-fold increase of monocyte
chemotactic protein-1 (MCP-1), relative to CONS. (B) RT-PCR assessment of
proinflammatory oxidases in frontal cortex tissue samples found an approximate three-fold
increase of NADPH oxidase (NOX2) mRNA, an approximate 80% increase of
cyclooxygenase-2 (COX2) mRNA, and no change in inducible nitric oxide synthase (iNOS)
mRNA, relative to CONS. (C) RT-PCR assessment of neuroimmune agonist mRNA in
frontal cortex tissue samples found an approximate 180% increase of S100 calcium binding
protein B (S100β), a two-fold increase of fibronectin (Fbn), and a 44% increase of myeloid
differentiation primary response gene 88 (MyD88), relative to CONS. RT-PCR analyses
were run in triplicate. * indicates p<0.05, ** indicates p<0.01, relative to CON rats.
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FIGURE 9. ADOLESCENT INTERMITTENT ETHANOL (AIE) EXPOSURE ALTERS THE
DEVELOPMENTAL TRAJECTORY OF THE NEUROIMMUNE SIGNALING SYSTEM,
LEADING TO UPREGULATION THAT PERSISTS INTO YOUNG ADULTHOOD
(A) A simplified schematic of AIE-induced cyclic activation of the innate immune signaling
system in the prefrontal cortex that persists into young adulthood. Ethanol (EtOH) exposure
causes nuclear release of high-mobility group box 1 (HMGB1 [Crews et al. 2013]) , which
becomes a proinflammatory cytokine (Yang et al. 2005). Ethanol also activates glial cells
(Qin and Crews 2012) to release proinflammatory cytokines (i.e., TNFα, MCP-1) and
oxidases (i.e., NOX2, COX2) that increase innate immune signal agonist expression (i.e.,
fibronectin, S100β). These proinflammatory cytokines, oxidases, and neuroimmune
signaling agonists increase the expression of Toll-like receptor 4 (TLR4), which facilitate
further release of HMGB1 and other proinflammatory signals establishing the cycle of
TLR4/HMGB1 innate immunity signaling (Hohne et al. 2013). Once the inflammagen (i.e.,
EtOH) is removed from this system, the activated innate immune signaling system continues
to release proinflammatory signals leading to upregulation of the receptor for advanced
glycation end products (RAGE) on neurons. (B) Schematic of the correlation of age of
drinking onset with neuroimmune signaling in the human post-mortem alcoholic
orbitofrontal cortex, relative to moderate drinking controls. (C) Schematic of the adolescent
maturational trajectory of neuroimmune signaling. (Top) Depicted is the maturational
trajectory of neuroimmune signaling from adolescence to young adulthood. (Bottom)
Depicted are AIE-induced changes to the maturational trajectory of neuroimmune signaling.
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Table 1
Case characteristics of human subjects.




Control 24 Male 43 Undetermined (Consistent withidiopathic cardiac arrhythmia) 20
Control 43 Male 66 Aspiration pneumonia 25
Control 44 Male 50 Ischemic heart disease 25
Control 46 Male 29 Acute myocardial infarction 25
Control 50 Male 30 Coronary artery disease 25
Control 50 Male 40 Haemopericardium 25
Control 53 Male 16 Dilated cardiomyopathy 25
Control 60 Male 28 Ischemic heart disease 25
Control 62 Male 46 Ischemic heart disease 25
Control 48 Male 24 Ischemic heart disease 29
Alcoholic 49 Male 16 Coronary artery thrombosis 14
Alcoholic 45 Male 7 Drowning 15
Alcoholic 49 Male 44 Ischemic heart disease 16
Alcoholic 61 Male 59 Myocarditis 16
Alcoholic 51 Male 27 Gastrointestinal hemorrhage 17
Alcoholic 61 Male 23 Atherosclerotic cardiovascular disease 17
Alcoholic 42 Male 41 Combined bromoxynil andalcohol toxicity 18
Alcoholic 50 Male 17 Ischemic heart disease 18
Alcoholic 44 Male 15 Ischemic heart disease 20
Alcoholic 43 Male 43 Carbon monoxide intoxication/Alcoholintoxication 25
PMI: post-mortem interval. Mean age of drinking onset for moderate drinking controls was (25±1) and for alcoholics was (18±1). Alcoholic
individuals tended to report an earlier age of drinking onset than moderate drinking controls.
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Table 3
Correlation of receptor for advanced glycation end products (RAGE) expression with the agonist high-





PrL 0.64 * 0.51 0.78 **
IL 0.80 ** 0.78 ** 0.86 ***
OFC 0.64 * 0.57 * 0.83 ***
Pearson’s r correlations were conducted for the three PFC regions assessed for RAGE and HMGB1+IR cells. HMGB1+IR cell counts in the
prelimbic cortex (PrL) and infralimbic cortex (IL) have been reported previously (Vetreno and Crews 2012). Although correlations do not prove
linkage, statistically significant associations were observed between RAGE+IR cells and HMGB1+IR cells in the PFC. These correlations provide
further evidence that HMGB1-RAGE signaling perpetuates brain regional expression of neuroimmune signaling. Pearson’s r correlation
coefficients were used with two-tailed significance (* p<0.05, ** p<0.01, *** p<0.001). OFC: orbitofrontal cortex.
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